HeyJaredTingmin Koe
- Indexed articles, last 90 days
- 51
- Latest publication
- Sep 29, 2026
- Outlet visibility, for NutraIngredients.com
- Top 1M sites
- Earliest in this view
- Jul 7, 2026
Latest articles
Singapore brand taps into pre-, pro- and postbiotics for eczema relief (opens the original)
Read excerpt
MIRIQA Dermabiotics is currently available in over 100 clinics, as well as the National Skin Centre and major hospital pharmacies across Singapore. A key ingredient is Lactobacillus rhamnosus IDCC RHT3201, which is the first postbiotic approved by the Korean FDA for its immune-balancing properties. In a 12-week clinical trial, the postbiotic was reported to reduce inflammatory markers eosinophil cationic protein (ECP) and interleukin-31 (IL-31) in children aged 1 to 12 with moderate atopic derma
PDRN: The next trending ingredient for beauty from within? (opens the original)
Read excerpt
First popularized as an aesthetic injectable by South Korean brand Rejuran, PDRN (polydeoxyribonucleotide) consists of short DNA fragments primarily sourced from the sperm cells of salmon trout or chum salmon, although there are now also vegan versions derived from microalgae. For consumers already using PDRN in topical skincare, oral supplements are being positioned as a complementary rather than competing approach within a broader beauty regimen. It is also being incorporated into formulations
Trend tracker: AI’s pros and cons, healthspan new product launches and more (opens the original)
Read excerpt
Consumer trust cannot be taken for granted as AI-generated information and increasingly informed audiences reshape how people assess brands and health claims, delegates heard at Vitafoods Asia in Bangkok. Brands can no longer rely on a single approach; they need to understand different cultures, values and audience expectations, said Gillian Fish, business growth strategist and founder of The 6AM Agency, in a presentation on ‘Brand Trust in the Age of AI, Outrage and Infinite Noise’. As health i
Elixinol Wellness to acquire Vitable amid global interest in personalized health (opens the original)
Read excerpt
The Australian Securities Exchange-listed company announced its plans to acquire Vitable for A$2.5m (US$1.7m) today (Sept. 24), subject to shareholders’ approval during its general meeting in early November. The acquisition payout, to be paid in shares, includes both unconditional and conditional components, namely an unconditional payout of A$1.25m and another A$1.25m subject to net revenue and direct EBITDA growth. An additional A$1m will be considered if Elixinol’s market capitalization excee
Industry, research experts surprised, disappointed at TGA’s Andrographis removal (opens the original)
Read excerpt
The TGA announced its decision to ban the use of Andrographis (Andrographis paniculata) in listed medicines on Sept. 18, citing concerns of allegic reactions, including anaphylaxis. Also known as the “King of Bitters” or Indian echinacea, the leafy green herb is native to South Asia and has a long history of use in traditional Ayurvedic and Chinese medicine to treat colds, flus and sore throat. As of 2025, the TGA noted that it had received 287 reports of anaphylaxis associated with Andrographis
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1M sites
For NutraIngredients.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.